ArticleCancers2025

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study.

Elena Fountzilas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.